Overview

Cannabidiol Use to Reduce Cravings in Individuals With Opioid Use Disorder on Buprenorphine

Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this week-long study is to determine the impact of cannabidiol on cue-induced cravings among individuals with opioid use disorder who are stable on sublingual buprenorphine treatment.
Phase:
Phase 2
Details
Lead Sponsor:
Brigham and Women's Hospital
Treatments:
Buprenorphine
Cannabidiol
Epidiolex